Navigation Links
Pfizer Inc and GoIndustry DoveBid Partner to Auction Surplus Equipment from R&D Facilities Across the United States
Date:6/30/2010

BALTIMORE, June 30 /PRNewswire/ -- GoIndustry DoveBid announces the Pfizer asset disposition program, which will see auctions of surplus assets from Pfizer's facilities across the United States. Over 500 lots per week will be available via online auction as part of GoIndustry DoveBid's ongoing BioPharma Exchange, over the upcoming months.

(Logo: http://photos.prnewswire.com/prnh/20100630/PH28915LOGO )

(Logo: http://www.newscom.com/cgi-bin/prnh/20100630/PH28915LOGO )

Each week's auction will include an outstanding selection of assets ranging from HPLC and NMR Systems to Mass Spectrometers and general lab equipment. The majority of assets come from working environments and have been maintained, as one would expect from a top tier company such as Pfizer.

"With GoIndustry DoveBid, we have undergone an extensive project to identify all the surplus assets in our facilities across the country," said Bill Carr, Asset Disposition Director, from Pfizer Inc. "We have been pleased with our past results and look forward to our upcoming participation in the BioPharma Exchange."

The GoIndustry DoveBid BioPharma Exchange is a weekly series of online auction sales. Buyers typically have 24 to 48 hours to bid on state-of-the-art, biotech lab, research & development, and pharmaceutical equipment from the world's leading pharmaceutical manufacturers including Pfizer, Merck, and Bristol-Myers Squibb Company.

The BioPharma exchanges -- featuring high quality Pfizer equipment -- are conducted weekly. For more information visit http://www.go-dove.com/exchanges/BioPharma.

To learn more about the Pfizer equipment available, contact Tom Laster at tom.laster@go-dove.com or telephone: +1 (650) 377-2646

Further information and interviews available on request

About GoIndustry DoveBid & Pfizer

GoIndustry DoveBid continues to provide asset management services for Pfizer, supporting the company's ongoing global assets recovery efforts. As a result of this relationship, Pfizer has reduced the number of surplus assets; experienced cost savings due to internal redeployment of equipment globally; and benefited from welcome cash injections from external sales. Over the past 7 years, several business units -- from Animal Health to Pfizer Global Research & Development and Global Manufacturing -- have taken advantage of this full service relationship.

GoIndustry DoveBid works with the business units to help identify surplus assets. Our expert team provides market intelligence to facilitate whether the assets are made available for redeployment internally, or for sale externally. At which point assets are appraised to give an indication their market value.

GoIndustry DoveBid offers a wide range of options for external sale including: online Auction, Private Treaty sales, or industry specific Exchanges -- a weekly series of online auction sales. Pfizer continues to be a major player in the weekly BioPharma Exchange.

About GoIndustry DoveBid

GoIndustry DoveBid is a leading provider of asset management services. If surplus or idle assets are no longer needed, we help organizations understand their worth, whether they can be re-deployed elsewhere in the business, or sell them on the used industrial goods marketplace.

GoIndustry DoveBid approaches the market with three distinct advantages. First, we have significant global reach so we are able to provide these services wherever they are needed. Second, most of our business is online, making it more efficient and convenient for both buyers and sellers whether it's for a single piece of equipment or a whole production line. Third, our knowledge of the market across multiple industry sectors is unsurpassed. Since 2000, we have collected information gathered from auctions all over the world. We leverage this rich data on a daily basis through accurate valuations and appraisals for the benefit of all our customers.

Find out more about us at www.go-dove.com or contact us to unlock the value of your assets.


'/>"/>
SOURCE GoIndustry DoveBid
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Pfizer Invites Public to View and Listen to Webcast of August 3 Conference Call With Analysts
2. Pfizer Prepares for Voluntary Withdrawal of U.S. New Drug Application and for Discontinuation of Commercial Availability of Mylotarg®
3. Pfizer And Epocrates Partner To Give Healthcare Providers Access To Medical Information Specialists For Medication Questions
4. Pfizer Appoints Mikael Dolsten President of Worldwide Research and Development
5. Pfizer Invites Public to View and Listen to Webcast of Pfizer Presentation at Healthcare Conference
6. Pfizer Reigns Supreme After Patent Cliff as Humira Kicks Avastin off Top Spot
7. Gelesis Unveils Novel Non-Invasive Capsulated Device for Obesity and Presents Clinical Data; Appoints Former Pfizer R&D President to Board
8. Pfizers Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts
9. President of Pfizer Vaccines, Mark Swindell, Named as the Healthcare Businesswomens Associations 2010 Honorable Mentor
10. VetCentric Announces Partnership With Pfizer Animal Health
11. Pfizer Selects ChemAxons Markush Platform
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016 Research ... Devices Global Market - Forecast to 2022" report to ... the treatment method for the patients with kidney failure, it ... excess fluid from the patient,s blood and thus the treatment ... potassium and chloride in balance. Increasing number ...
(Date:6/23/2016)... -- In a startling report released today, National Safety Council ... comprehensive, proven plan to eliminate prescription opioid overdoses. Prescription ... are tackling the worst drug crisis in recorded U.S. history, assigned ... Kentucky , New Mexico , ... 28 failing states, three – Michigan , ...
(Date:6/23/2016)... , June 23, 2016 ... CAPR ), a biotechnology company focused on ... today announced that patient enrollment in its ongoing ... Duchenne) has exceeded 50% of its 24-patient target. ... in the third quarter of 2016, and to ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now reveal their ... Cut Pro X," said Christina Austin - CEO of Pixel Film Studios. , ... Pro X users can now reveal the media of their split screens with ...
(Date:6/27/2016)... , ... June 27, 2016 , ... TopConsumerReviews.com recently awarded ... Eyeglasses . , Millions of individuals in the United States and Canada wear ... a way to both correct vision and make a fashion statement. Even celebrities use ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... that was developed to enhance the health of felines. The formula is all-natural and ... main herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, can now ... and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings ... The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the ...
(Date:6/25/2016)... ... 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his ... David Geffen School of Medicine at UCLA. He trained in Internal Medicine at Scripps ... in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to ...
Breaking Medicine News(10 mins):